Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 871 to 880 of 1535

TitleReference numberPublishedLast updated
Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancerTA639
Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma (terminated appraisal)TA634
Ramucirumab with erlotinib for untreated EGFR-positive metastatic non-small-cell lung cancer (terminated appraisal)TA635
Eculizumab for treating refractory myasthenia gravis (terminated appraisal)TA636
Ranibizumab for treating diabetic retinopathy (terminated appraisal)TA637
Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedureTA626
Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary interventionIPG673
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasiaMTG49
MolecuLight i:X for wound imagingMIB212
Actim Pancreatitis for diagnosing acute pancreatitisMIB218

Results per page

  1. 10
  2. 25
  3. 50
  4. All